Synoste

Synoste

Synoste

Synoste develops next-generation medical solutions for the treatment and correction of skeletal deformities. Its implants for lengthening limbs are based on a mechanism using smart metals that operate safely and painlessly for the patient.
Founded
2012
Raised
$8.1M
Follow us
Alexa global traffic share
Latest funding Show all
€5,100,000
Venture capital - 2018
Lifeline Ventures AO Invest
Undisclosed amount
Venture capital - 2016
Evonik Venture Capital
Team Size
2
Employees
Location
Headquarters
€5,100,000 Venture capital
FinSMEs

Medical Device Company Synoste Raises €5.1M

Funding
$2,200,000 Venture capital (Series A)
High-Tech Gründerfonds

Synoste Oy raises € 2.2 M in the first closing of A-round financing to acquire CE-approval for a next generation implant...

Venture capital
evonik

Venture Capital: Evonik invests in SYNOSTE, a medical technology start-up in Düsseldorf and Helsinki Industries - Specia...